Search for: "CVS Pharmaceuticals, Inc." Results 21 - 40 of 784
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Federal Court Addresses Potiential Liability of Drug Manufacturer in Products Liability Case
8 Sep 2022, 5:00 am
., Inc., No. 21-CV-5486 (E.D. [read post]
Tort Talk - http://www.torttalk.com/
Pharmaceutical Manufacturer Agrees to $900 Million Dollar False Claims Act Settlement to Resolve Kickback Claims
10 Aug 2022, 12:00 pm by Michael J. Podberesky, Kate Hardey, Samuel C. Bernstein and James E. Lego
Action No. 12-cv-10601-IT (D. [read post]
Subject to Inquiry - http://www.subjecttoinquiry.com/
Pfizer Fails Again in Its Quixotic Quest for Imprimatur of Its Proposal to Provide Direct Medicare Copay Assistance
25 Jul 2022, 1:52 pm by jeffreynewmanadmin
” Pfizer, Inc. v. [read post]
Whistleblower Blog - https://www.jeffreynewmanlaw.com/blog/
Recent Hot Topics and Developments in Trade Secrets Law
3 Jun 2022, 10:03 am by Robert B. Milligan
Aerometals, Inc., 16-cv-02249, 2021 WL 978953, at *1 (E.D. [read post]
Trading Secrets - http://www.tradesecretslaw.com/
court declines to decide between Eveready and Squirt and lets a linguist in too
26 Apr 2022, 5:32 am by Rebecca Tushnet
Evofem Biosciences, Inc., 2022 WL 1013285, No. 20-CV-82296-RUIZ/REINHART (S.D. [read post]
43(B)log - http://tushnet.blogspot.com/
More Than $870 Million To Settle Opioid Case in Florida
21 Apr 2022, 3:26 pm by PP&S Team
CVS Health Corp. and CVS Pharmacy Inc. will pay the state $484 million, while Teva Pharmaceuticals Industries Ltd. will pay $195 million, Allergan PLC over $134 million, and Endo Health Solutions $65 million. [read post]
South Florida Personal Injury News and Trends - https://panterlaw.com/blog/
More of a Bad Thing? Thoughts on FDA’s Proposal to Extend the FDR Process to Withdrawals of Accelerated Approvals
12 Apr 2022, 6:14 pm by Kurt R. Karst
  See Vanda Pharmaceuticals, Inc. v. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Despite Setbacks in Court, California’s Ban on Pharmaceutical Pay-For-Deals Could Still Recover
24 Mar 2022, 12:04 pm by Zak Gowen
Actavis, Inc., 570 U.S. 136 (2013), which held that such payments are unlawful when they are “large and unjustified. [read post]
Antitrust Today - https://constantinecannon.com/practice/antitrust-litigation-counseling/antitrust-today/
Jacquety v Baptista, 549 F.Supp.3d 293 ( S.D. N.Y., 2021) [France][Petition denied][Costs]
20 Mar 2022, 10:35 am by Joel R. Brandes
” Endo Pharmaceuticals, Inc. v. [read post]
A Child is Missing - http://joelbrandes.blogspot.com/
Improper Reliance upon Regulatory Risk Assessments in Civil Litigation
19 Mar 2022, 2:09 pm by admin
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
Tortini - http://schachtmanlaw.com/blog/
Biogen loses to Mylan in request for rehearing over issues in patent for multiple sclerosis [MS] drug related to fumarates
17 Mar 2022, 2:32 pm by Lawrence B. Ebert
Mylan Pharmaceuticals Inc. [read post]
IPBiz - http://ipbiz.blogspot.com/
Rx label and database linkages plausibly deceive consumers; mostly not precluded by FDCA
7 Feb 2022, 10:32 am by Rebecca Tushnet
H-2 Pharma, LLC, 2022 WL 327738, No. 2:20-CV-753-ECM (M.D. [read post]
43(B)log - http://tushnet.blogspot.com/
Challenges to the Application of the Chinese State Secrets Law Abroad as Sword or Shield--A First Cut in In Re Valsartan, Losartan, and Irbesartan Products Liability Litigation (US DC NJ)
5 Jan 2022, 7:16 am
") A New Jersey federal judge backed a special master's order that Zhejiang Huahai Pharmaceutical Co. [read post]
Law at the End of the Day - http://lcbackerblog.blogspot.com/
Guest Post: Avoiding Bumps in the Road to Coverage: Limitations on the “Bump-Up Exclusion”
28 Dec 2021, 9:42 am by Kevin LaCroix
CV N18C-09-210, 2021 WL 347015, at *21 (Del. [read post]
The D & O Diary - http://www.dandodiary.com/
Guest Post: D&O Risks and Challenges for Pharmaceutical Companies and their Insurers
1 Dec 2021, 1:29 pm by Kevin LaCroix
Pfizer, Inc. [read post]
The D & O Diary - http://www.dandodiary.com/
Chancery Court Highlights Importance of Delivering Nomination Notices Ahead of Advance Notice Deadlines
28 Nov 2021, 7:58 am
CytoDyn Inc., No. 2021-CV-0728-JRS (Del. [read post]
The Harvard Law School Corporate Governance Blog - http://blogs.law.harvard.edu/corpgov
The Month in Qui Tam Cases (So Far)
19 Nov 2021, 10:33 am by Ana Popovich
Professional Compounding Centers of America, Inc., No. 5:14-cv-212 (W.D. [read post]
Whistleblower Protection Blog - http://www.whistleblowersblog.org/
Guest Post: SCA Loss Mitigation is Critical for D&O Profitability
11 Nov 2021, 2:07 pm by Kevin LaCroix
Nessim MezrahiIn the following guest post, Nessim Mezrahi takes a detailed look at the factors driving D&O profitability and the securities class action loss mitigation steps insurers can take to improve profitability. [read post]
The D & O Diary - http://www.dandodiary.com/
Pharmacy Deliveries Remain Target for Independent Contractor Misclassification Claims: October 2021 News Update
9 Nov 2021, 6:40 am by Richard Reibstein Esq.
Omnicare, Inc., No. 5:19-cv-00484 (S.D. [read post]
Independent Contractor Compliance Legal Blog - http://independentcontractorcompliance.com/
NY State Opioid Trial Continues With Defense Witnesses to Set to Testify
21 Oct 2021, 9:50 am by Simmons Hanly Conroy
Leading up to the trial’s opening arguments, several original defendants, including Johnson & Johnson and the pharmacies CVS, Walgreens, Rite-Aid and Wal-Mart, were severed from the trial. [read post]
Simmons Firm Law Blog - http://www.simmonsfirm.com/blog/